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Abstract Precision-cut slices of normal adult rat liver main- 
tained in serum-free medium remain hormone- and endotoxin- 
responsive for at least 48 h. They respond to glucocorticoid 
(dexamethasone) with the induction of the ghiconeogenic enzyme 
tyrosine aminotransferase (TAT), as determined by enzymatic 
activity and by the increase in enzyme protein. Furthermore, 
endotoxin (LPS) induced nitric oxide synthase II (i-NOS), and 
this induction is repressed, similarly to the in vivo situation, by 
dexamethasone (DEX). All increases are inhibited by cyclohex- 
imide (CHX). The length of the period of responsiveness uggests 
that this organ culture system might be generally useful for 
studying the modulation of liver gene expression by physiological 
and pathological influences. 
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1. Introduction 
The complexity of liver structure and the multiplicity of 
metabolic, homeostatic, endocrine and detoxification func- 
tions performed by the organ [1] have resulted in numerous 
efforts to develop in vitro systems that allow the study of 
single functions under controlled environmental conditions. 
These systems all share the characteristic that they eliminate 
the influence of other organs and of the circulatory system, 
thus providing conditions intermediate b tween 'test tube bio- 
chemistry' and the in vivo situation. However, most of these 
systems also share the characterstic of being immersed in the 
highly variable [2] medium component fetal calf serum. 
Improvements in the standardization f primary cultures of 
hepatocytes have allowed the analysis of a number of reac- 
tions performed by these cells, and of their response to phys- 
iological and pathological (e.g. xenobiotic) stimuli [3]. These 
developments have also allowed to study specific functions of 
the other several cell types of the normal iver and aspects of 
their interactions with hepatocytes [4]. 
Functionally differentiated hepatocyte cultures have a lim- 
ited life span and, in spite of improvements in the mainte- 
nance of differentiated properties by additives to the culture 
medium, components of the extracellular matrix or by differ- 
ent forms of coculture, a decline of liver specific functions 
cannot be prevented [3,5,6]. Furthermore, the advantages of 
pure-cell systems are endowed with the problem of missing 
organotypic ell-cell and ceI1-ECM interactions [7]. There- 
fore, results with these systems cannot be directly extrapolated 
to the in vivo situation. 
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To overcome these problems, in vitro systems have been 
developed, in which the organ structure is at least partially 
maintained for a certain time [8]. In practice, however, diffi- 
culties in ensuring an adequate nutrient and oxygen supply 
leads to short survival times and a severe loss of specific liver 
functions. Among these more complex, organotypic systems, 
thin liver fragments, 'slices' [9], are endowed with some ad- 
vantages: metabolites and substances to be tested are elimi- 
nated and can reach the cells by diffusion, and a relatively 
large number of tests might be performed with material from 
a single liver. Thus, the development of precision-cut liver 
slices [10] appears to have overcome some of the major lim- 
itations of other organotypic systems, even though resorting 
to the efficient, but artificial nutrient and oxygen supply by 
diffusion, as opposed to the circulatory system [3]. 
In spite of the limitations, the obvious advantages of the 
system and a series of interesting experimental set ups [11,12] 
have made it very attractive. As a consequence a large number 
of publications have been devoted to the description of its 
viability on the basis of measurements of general cellular 
parameters (e.g. intracellular K + and ATP, incorporation of 
[3H]leucine, MTT-reduction, LDH release [13]). 
By comparison, the study of liver-specific functions has 
proven to be less forwarding, and the problem of short useful 
periods (8 h [14]) has not yet been satisfactory solved. In some 
cases a pretreatment of the animals has yielded 'liver-specific' 
in vitro results (e.g, with LPS [15], aroclor 1254 [16], pheno- 
barbital [17] or adrenalectomy [18]). These approaches do not 
provide an alternative for studies requiring large numbers of 
laboratory animals. In an attempt to overcome some of these 
limitations, we have established an organ culture system, in 
which liver-specific hormone responsiveness and the capacity 
to react in a liver-specific manner to bacterial endotoxin (LPS) 
was maintained for at least 48 h. 
2. Materials and methods 
2.1. Animals 
Male Lewis rats (Charles River), with a body weight of about 275- 
300 g were housed under controlled environmental conditions with a 
defined light and darkness cycle, and with unrestricted access to food 
and water. To avoid variability resulting from circadian rhythms of 
liver functions the preparations were always performed at the same 
time of the day. All experiments were performed in agreement with 
the German guidelines for the care of laboratory animals. 
2.2. Organ culture 
The animals were killed by CO2 lethal narcosis. After exsanguina- 
tion the livers were immediately removed and kept in ice-cold (4°C) 
PBS (phosphate-buffered saline) until slicing. After rinsing thoroughly 
in several changes of buffer, liver lobes were trimmed into blocks of 
1 × 1.5 cm, from which slices of 250-300 Ixm thickness were cut using 
an automatic tissue slicer (Science Services, Munich). Slices were col- 
lected in cold (4°C) L-15 medium supplemented with 10% fetal calf 
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serum followed by a 24 h pre-incubation i L-15 supplemented with 
10% FCS, 4 mM L-glutamine and 15 mM Hepes buffer (pH 7.2). All 
incubations were performed in media without antibiotics. After the 1- 
day pre-incubation, experiments were continued in serum-free L-15 
medium and, where indicated, the medium was supplemented with 
dexamethasone (DEX; 25 50 /aM), LPS (20 lag/ml; 0111 :B4 Sigma, 
Deisenhofen, Germany). Unless indicated otherwise all chemicals were 
purchased from Sigma. 
2.3. Enzyme activity 
Determinations of TAT (EC 2.6.1.5.) activity were performed as 
described [19]. Specific activity was expressed as the amount of en- 
zyme forming 1 lamol of p-hydroxyphenylpyruvatelmin/mg protein at 
37°C. Protein concentration was measured by the Bradford method 
with BSA as a standard [20]. 
2.4. Western blotting 
For immunoblotting the slices were homogenized in eight volumes 
of reducing sample buffer and boiled for 10 min at 90°C. After sep- 
aration on 5 15% PAA gels the proteins were blotted onto nitrocel- 
lulose (Schleicher and Schuell) and detected with ECL (Amersham) as 
recomended by the supplier. Equal amounts of proteins per slot were 
confirmed by staining the blots with Ponceau-S [21]. Tyrosine amino- 
transferase (TAT) was detected with a polyclonal rabbit antibody 
against he rat enzyme (a kind gift of G. Schfitz, DKFZ, Heidelberg) 
and NOS-II was demonstrated with a monoclonal antibody against 
i-NOS from macrophages (Transduction Laboratories, Lexington, 
KY). Analysis of the scanned blots was performed with a recently 
developed Macintosh program [22]. 
3. Results 
3.1. TAT  activity and inducibility 
As shown in Fig. 1 the serum-free organ culture system 
responds readily to glucocorticoids with a time-dependent in- 
crease in TAT activity. The increase in enzymatic activity is 
prevented by cycloheximide (CHX), indicating its dependence 
on new protein synthesis. The induction proceeds more slowly 
than in vivo (Fig. 2), but the capacity of the system to respond 
to the hormone is similar to the organ in vivo, as shown by 
the activity obtained after longer incubation times and after a 
brief 'protective' [23] pretreatment with the glucocorticoid. 
The induction was further confirmed by the increase in the 
amount of the 54 kDa TAT protein, specifically detected with 
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Fig. 1. Glucocorticoid induction of TAT in liver slices during the 
second day of culture. Enzyme activity was measured 3 and 6 h 
after adding DEX (25 and 50 /aM). CHX (8 /ag/ml) was added to 
the incubation with the higher hormone concentration. All treat- 
ments were started after the 24 h pre-incubation. Results are from 
four independent experiments. 
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Fig. 2. Comparison of TAT expression i  vivo and in long-term or- 
gan culture. The in vivo induction was measured 6 h after an i.p. 
injection of DEX (3 mg/kg) and i.p. DEX + CHX (50 mg/kg). The 
in vitro results correspond to slices treated for 6 and 24 h with 
DEX (50 /aM) and, in addition, to slices pre-incubated for 6 h in 
the presence of the hormone followed by a 18 h incubation in ser- 
um-free medium and then again for 6 h with DEX (50 /.tM). All 
treatments were started after the 24 h pre-incubation. Data are ex- 
pressed as percent of control. Mean specific activities in vivo: 21.9 
and in vitro (24 h incubation): 10.3 /amol/min/mg protein, respec- 
tively. 
the polyclonal antibody against the purified enzyme, and the 
prevention of this increase by cycloheximide (Fig. 3). 
The liver is also a major target organ for endotoxin [24], 
but the data obtained with primary cultures of hepatocytes do 
not adequately represent he complex interactions that occur 
in vivo [25]. The long-term liver organ culture system shows 
the typical liver gene expression response to endotoxin with 
induction of nitric oxide synthase II (NOS-II) and also the 
prevention of this induction by dexamethasone (Fig. 4). 
These results indicate that in this serum-free organ culture 
system both induction and repression of gene expression can 
proceed with results comparable to the in vivo situation. 
4. Discussion 
The results now reported show that precision-cut slices of 
normal, untreated adult rat liver can be used for the study of 
liver-specific functions for at least 48 h, as demonstrated by 
the induction of TAT and the induction and repression of 
NOS. The conditions achieved provide stable organ cultures 
well beyond the reccommended [14] first 8 h after obtention of 
the slices, a period during which some liver functions may be 
altered by the tissue processing conditions. 
TAT was chosen as one of the most extensively studied 
examples of liver-specific hormone responsive systems [26]. 
Expression of the enzyme begins in the rat shortly after birth. 
In culture its expression can be maintained for some time by 
providing the primary hepatocytes with a number of hor- 
mones [27] and with extracellular matrix [28,29]. In contrast 
to other hormonal studies [30] the changes in TAT activity 
depend on a de-novo synthesis of the enzyme, thus providing 
an excellent parameter for determining intact protein synthe- 
sis, 'hepatic quality' and hormone-modulated gene expression 
at the same time [31,32]. The somehow slower than in vivo 
reaction to the modulators is assumed to be a consequence of 
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Fig. 3. Immunoblot demonstration f TAT induction. (a) Homoge- 
nate from adult rat liver. (b) Untreated liver slices incubated for 24 
h (control). (c) Slices treated with DEX (50 gM) for 24 h. (d) Slices 
treated as for (c) but supplemented a ditionally with CHX (8 ~tg/ 
ml). All treatments were started after the 24 h pre-incubation. TAT 
immunoblots were performed routinely for all experiments. 
the in vitro situation with exchange of metabolites and sub- 
strates by diffusion, as opposed to the in vivo situation, with 
an intact circulatory system. In its present state of develop- 
ment the system provides conditions for gene expression stud- 
ies without the need of large numbers of experimental ni- 
mals. 
The inducible form of NOS (i-NOS/NOS-II) can represent 
the predominant enzyme isoform in the liver [33]. Its patho- 
physiologic importance in endotoxemic, antimicrobic and 
antitumorigenic events is rapidly becoming apparent [34]. 
Current evidence indicates that in addition to the cells of 
the reticuloendothelial system and hepatocytes, presumably 
also some of the other cell types of the organ can either ex- 
press or modulate the expression of the enzyme. However, the 
general picture is still incompletely understood [35]. The organ 
culture system might, therefore, contribute to a better under- 
standing of some functions of hepatic NOS under controlled 
conditions, while maintaining organ specific cell-cell and cell 
ECM interactions and without resorting to large series of 
animal experiments. In the serum-free culture system endotox- 
in (LPS) induces i-NOS directly and not only at standard (10 
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Fig. 4. Expression of i-NOS in long-term slice culture of normal 
adult rat liver. (a) Positive control (130 kDa i-NOS) from induced 
macrophages (Transduction Laboratories). (b) Liver slices cultured 
for 24 h without additions (control). (c) Slices incubated for 24 h 
with LPS (20 Isg/ml). (d) Slices incubated for 24 h with LPS + 
CHX (8 ~tg/ml). (e) Slices incubated for 24 h with LPS + DEX (50 
~tM). All treatments were started after the 24 h pre-incubation. The 
results shown are representative of four independent experiments. 
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20 lag/ml) but also at much lower (2 },tg/ml) concentrations 
(unpublished results). In contrast, standard cell culture sys- 
tems have been reported to require additional treatments 
with cytokines [36], macrophage-conditioned medium, Kupf- 
fer cell co-cultivation or hepatocytes prepared from endotox- 
in-pretreated animals ('primed hepatocytes' [33,36]). These re- 
quirements are obviated with our organ culture system which, 
as now described, can provide from a single liver a large 
number of samples for the study of induction (TAT, i-NOS) 
and repression (i-NOS) of gene expression. 
In summary, in its present state of development, the long- 
term organ culture system allows the analysis of gene expres- 
sion phenomena modulated by glucocorticoids and endotoxin. 
The near in vivo efficiency at which the reactions occur sug- 
gests a wider applicability of this organ culture system for the 
study of liver reactions to physiological and pathological in- 
fluences. 
Acknowledgements." We thank Prof. G. Schiitz, DKFZ, Heidelberg for 
TAT antibody. The work was partially supported by DFG through 
Sonderforschungsbereich 156.
References 
[1] Zakim, D. and Boyer, T.D. (1990) Hepatology. A Textbook of 
Liver Disease. Saunders, Philadelphia, PA. 
[2] Honn, K., Singley, J. and Chavin, W. (1975) Proc. Soc. Exp. Bio. 
Med. 149, 344-347. 
[3] Li, A.P. (1994) in: In Vitro Toxicology, Vol. 10, pp. 195-220 
(Gad, S.C., Ed.) Raven Press, New York. 
[4] Wisse, E., Knook, D.L. and Wake, K. (1995) Cells of the Hepa- 
ticsinusoid, Vol. 5, Kupffer Cell Foundation, Leiden. 
[5] Dich, J. and Grunnet, N. (1990) in: Animal Cell Culture, Vol. 15, 
pp. 161 176 (Pollard, J.W. and Walker, J.M., Eds.) Humana 
Press, Clifton, NJ. 
[6] McMillan, J.M., Shaddock, J.G., Casciano, D.A., Arlotto, M.P. 
and Leakey, J.E.A. (1991) Mutation Res. 249, 81-92. 
[7] Maher, J.J. and Bissel, D.M. (1993) Sem. Cell Biol. 4, 189-201. 
[8] Trowell, D.A. (1959) Exp. Cell Res. 16, 118 147. 
[9] Krumdieck, C.L., Dos Santos, J.E. and Ho, K.-J. (1980) Anal. 
Biochem. 104, 118-123. 
[10] Parrish, A.R., Gandolfi, A.J. and Brendel, K. (1995) Life Sci. 57, 
1887-1901. 
[11] Beamand, J.A., Price, R.J., Blowers, S.D., Wield, P.T., Cunning- 
hame, M.E. and Lake, B.G. (1994) Food Chem. Toxicol. 32, 
819 829. 
[12] Lake, B.G., Charzat, C., Tredger, J.M., Renwick, A,B., Bea- 
mand, J.A. and Price, R.J. (1996) Xenobiotica 26, 297-306. 
[13] Fisher, R., Shaughnessy, R., Jenkins, P., Austin, M., Roth, G., 
Gandolfi, A. and Brendel, K. (1995) Toxicol. Method 5, 99-113. 
[14] Goethals, F. and Roberfroid, M. (1995) in: Modulation of Cel- 
lular Responses in Toxicity, pp. 265-281 (Galli, C.L., Goldberg, 
A.M. and Marinovich, M., Eds.) Springer, Berlin. 
[15] Luster, M.I., Germolec, D.R., Yoshida, T., Kayama, F. and 
Thompson, M. (1994) Hepatology 19, 480488. 
[16] Wolfgang, G., Donarski, W. and Petry, T. (1990) Tox. App. 
Pharmacol. 106, 63-70. 
[17] Fisher, R., Brendel, K. and Hanzlik, R.P. (1993) Chem. Biol. 
Interact. 88, 191-208. 
[18] Hart, A., Mattheyse, F.J. and Balinsky, J.B. (1983) In Vitro 19, 
841-852. 
[19] Granner, D.K. and Tomkins, G.M. (1970) Methods Enzymol. 
17A, 633-637. 
[20] Bradford, M. (1976) Anal Biochem. 72, 248 254. 
[21] Harlow, E. and Lane, D. (1988), pp. 726, Cold Spring Harbor 
Laboratory Press, Cold Spring Harbor. 
[22] Seebacher, T. and Bade, E.G. (1996) Electrophoresis, in press. 
[23] Guillouzo, A., Morel, F., Ratanasavanh, D., Chesne, C. and 
Guguen-Guillouzo, C. (1990) Toxicol. in Vitro 4, 415~J,27. 
[24] Baumann, H. and Gauldie, J. (1994) Immunol. Today 15, 74-80. 
[25] Baumann, H. (1989) In Vitro Cell. Dev. Biol. 25, 115-126. 
54 K. Sultan et al./FEBS Letters 394 (1996) 51-54 
[26] Schmid, E., Schmid, W., Jantzen, M., Mayer, D., Jastroff, B. and 
Schlitz, G. (1987) Eur. J. Biochem. 165, 499 506. 
[27] Dietrich, J.-B. (1992) Cell. Mol. Biol. 38, 95 114. 
[28] Rabergh, C.M., Kane, A.S., Reimschuessel, R. and Lipsky, 
M.M. (1995) Methods Cell Sci. 17, 207-215. 
[29] Kato, S., Sugiura, N., Kimata, K., Kujiraoka, T., Toyoda, J. and 
Akamatsu, N. (1995) Cell Struct. Funct. 20, 199-209. 
[30] McKee, R.L., Hruby, V.J., Trivedi, D.B,, Johnson, D.G., Gan- 
dolfi, A.J., Krumdieck, C.L. and Brendel, K. (1988) J. Pharma- 
col. Methods 19, 339-354. 
[31] Coleman, W.B., Smith, G.J. and Grisham, J.W. (1994) J. Cell 
Physiol. 161,463-469. 
[32] Kocarek, T.A., Schuetz, E.G. and Guzelian, P.S. (1994) Biochem. 
Pharmacol. 48, 1815-1822. 
[33] Suzuki, H., Menegazzi, M., Deprati, A.C., Mariotto, S. and Ar- 
mato, U. (1995) Adv. Neuroimmunol. 5, 379-410. 
[34] Nathan, C. and Xie, Q. (1994) Cell 78, 915-918. 
[35] Buttery, L.D.K., Evans, T.J., Springall, D.R., Carpenter, A., 
Cohen, J. and Polak, J.M. (1994) Lab. Invest. 71, 755-764. 
[36] Morris, S.M. and Billiar, T.R. (1994) Am. J. Physiol. 266, E829- 
E839. 
